{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:25:27Z","timestamp":1760369127169},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jpba.2013.08.032","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:18:39Z","timestamp":1377879519000},"page":"81-91","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Parallel achiral\u2013chiral determination of oxybutynin, N-desethyl oxybutynin and their enantiomers in human plasma by LC\u2013MS\/MS to support a bioequivalence trial"],"prefix":"10.1016","volume":"88","author":[{"given":"Primal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daxesh P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallika","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Guttikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav S.","family":"Shrivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.08.032_bib0005","series-title":"Stereoselectivity in Drug Action and Disposition: An Overview","first-page":"139","article-title":"Chiralit drug design development","author":"Patel","year":"2004"},{"key":"10.1016\/j.jpba.2013.08.032_bib0010","first-page":"151","article-title":"Oxybutynin extended release for the management of overactive bladder: a clinical review","volume":"3","author":"Arisco","year":"2009","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jpba.2013.08.032_bib0015","first-page":"19","article-title":"Oxybutynin: an overview of the available formulations","volume":"2","author":"McCrery","year":"2006","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.jpba.2013.08.032_bib0020","first-page":"12","article-title":"A comparative review of oxybutynin chloride formulations: pharmacokinectics and therapeutic efficacy in overactive bladder","volume":"12","author":"Kennelly","year":"2010","journal-title":"Rev. Urol."},{"key":"10.1016\/j.jpba.2013.08.032_bib0025","unstructured":"DITROPAN\u2122 (oxybutynin chloride) Product Information. Sanofi-Aventis, One Onslow, Guildford, Surrey, UK, http:\/\/products.sanofi.com.au\/aus_pi_ditropan.pdf."},{"key":"10.1016\/j.jpba.2013.08.032_bib0030","first-page":"1012","article-title":"Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and thier enantiomers with those of racemic terodiline","volume":"48","author":"Smith","year":"1998","journal-title":"Arzneimittelforschung Drug Res."},{"key":"10.1016\/j.jpba.2013.08.032_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-4347(01)00497-2","article-title":"Plasma protein binding study of oxybutynin by high-performance frontal analysis","volume":"768","author":"Shibukawa","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2013.08.032_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-4347(01)00499-6","article-title":"Binding study of desethyloxybutynin using high-performance frontal method","volume":"768","author":"Shibukawa","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2013.08.032_bib0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.0306-5251.2001.01463.x","article-title":"Effect of OROS\u00ae controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride","volume":"52","author":"Satyan","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2013.08.032_bib0050","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1010956832113","article-title":"Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyl oxybutynin following oral and transdermal administration of the racemate in healthy volunteers","volume":"18","author":"Zobrist","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2013.08.032_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0091270006297226","article-title":"Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutynin","volume":"47","author":"Reiz","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2013.08.032_bib0060","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/00498259209053145","article-title":"Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young elderly and frail elderly volunteers","volume":"22","author":"Hughes","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2013.08.032_bib0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1022259011052","article-title":"Pharmacokinetics and metabolism of transdermal oxybutynin: in vitro and in vivo performance of a novel delivery system","volume":"20","author":"Zobrist","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2013.08.032_bib0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0731-7085(02)00644-1","article-title":"Sensitive determination of oxybutynin and desethyloxybutynin in dog plasma by LC\u2013ESI-MS\/MS","volume":"31","author":"Kim","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.08.032_bib0075","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.lfs.2004.11.013","article-title":"In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin","volume":"76","author":"Oki","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2013.08.032_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9673(96)00756-X","article-title":"Chiral bioanalysis by normal phase high-performance liquid chromatography\u2013atmospheric pressure ionization tandem mass spectrometry","volume":"759","author":"Alebic-Kolbah","year":"1997","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2013.08.032_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/00498250600976088","article-title":"Stereoselective pharmacokinetics of oxybutynin and N-desethyloxybutynin in vitro and in vivo","volume":"37","author":"Mizushima","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2013.08.032_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jchromb.2008.05.023","article-title":"Enantioselective analysis of oxybutynin and N-desethyloxybutynin with application to an in vitro biotransformation study","volume":"875","author":"Da Fonseca","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2013.08.032_bib0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpba.2013.06.024","article-title":"Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC\u2013MS\/MS to support a bioequivalence study","volume":"84","author":"Sharma","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2013.08.032_bib0100","unstructured":"Guidance for Industry: ICH E6 Good Clinical Practice, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), 1996."},{"key":"10.1016\/j.jpba.2013.08.032_bib0105","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4155\/bio.11.76","article-title":"Incurred sample reanalysis: a decisive tool in bioanalytical research","volume":"3","author":"Yadav","year":"2011","journal-title":"Bioanalysis"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513003877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513003877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T11:22:49Z","timestamp":1539429769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513003877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":21,"alternative-id":["S0731708513003877"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.08.032","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parallel achiral\u2013chiral determination of oxybutynin, N-desethyl oxybutynin and their enantiomers in human plasma by LC\u2013MS\/MS to support a bioequivalence trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}